Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024

15 Nov 2024 08:00 CET

Regulatory News:

At its meeting of November 13, 2024, the Board of Directors of Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), (“Valerio Therapeutics” or the “Company”) decided to appoint Mr Julien Miara as CEO and Chairman of the Board of Valerio Therapeutics, succeeding Ms Shefali Argawal, effective immediately.

Future evolutions related to the Company’s governance will be announced at a later date.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241114125852/en/

Valerio Therapeutics
Investor Relations
ir@valeriotx.com
France: +33 (0) 1 70 38 33 99
U.S.: +1 617 366 1022